Gentulizumab (Gensci-059) is a humanized IgG4 monoclonal antibody specifically designed to target CD47. This antibody demonstrates robust binding affinity for CD47 across both human and monkey tissues, effectively disrupting the CD47-SIRP?? interaction. Such inhibition plays a critical role in modulating antitumor immunity, making Gentulizumab a potent agent for antitumor activity studies. For experimental control purposes, Human IgG4 (S228P) kappa serves as the appropriate isotype control for Gentulizumab.
Gentulizumab (Gensci-059) is a humanized IgG4 monoclonal antibody specifically designed to target CD47. This antibody demonstrates robust binding affinity for CD47 across both human and monkey tissues, effectively disrupting the CD47-SIRP?? interaction. Such inhibition plays a critical role in modulating antitumor immunity, making Gentulizumab a potent agent for antitumor activity studies. For experimental control purposes, Human IgG4 (S228P) kappa serves as the appropriate isotype control for Gentulizumab.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
